Abstract:STUDY QUESTION: Do long non-coding RNA (lncRNA) and messenger RNA (mRNA) profiles in follicular fluid from mature and immature ovarian follicles differ between healthy women and women with polycystic ovary syndrome (PCOS)? SUMMARY ANSWER: lncRNA and mRNA profiles in follicular fluid from both mature and immature ovarian follicles differed significantly between healthy women and PCOS patients. WHAT IS KNOWN ALREADY: Unlike microRNAs, which have been extensively studied, lncRNAs present in follicular fluid have never been sequenced and the biological associations of lncRNAs in healthy follicles and follicles in women who develop PCOS remain largely unknown. STUDY DESIGN, SIZE, DURATION: A total of 18 subjects (8 controls and 10 PCOS patients) were recruited to participate in this study. Recruitment took place from May 2016 to September 2016. PARTICIPANTS/ MATERIALS, SETTING, METHODS: The follicular fluid donors underwent their first round of in-vitro fertilization treatment. Follicle size was determined based on the average follicular diameter, and follicular fluid samples were collected from mature follicles (17-22 mm) and matched-immature follicles (8-13 mm). RNA sequencing was performed on follicular fluids from mature and immature follicles of healthy women and PCOS patients. MAIN RESULTS AND THE ROLE OF CHANCE: A total of 1583 novel lncRNAs were identified in 36 human follicular fluid samples and some were expressed differently in healthy and PCOS women. lncRNAs associated with the metabolic process were highly enriched in the follicular fluid of mature follicles from the PCOS group versus the healthy group. In the PCOS group, nervous system process lncRNAs were highly enriched in the follicular fluid of mature versus immature follicles, whereas in the healthy group, lncRNAs associated with junction adhesion and communication-related processes were highly enriched in the follicular fluid of mature versus immature follicles. In addition, differentially expressed mRNAs were principally linked to olfactory transduction pathways. Consistent results from Gene Set Enrichment Analysis (GSEA) and Gene Ontology (GO) indicated that telomere maintenance and MAPK and Wnt pathways may be conserved processes, active in follicular development, and monosaccharide biosynthesis might provide possible pathway markers to distinguish between normal and PCOS follicles. We constructed gene co-expression networks that identified many co-regulatory relationships among follicular fluid lncRNAs, mRNAs, and PCOS phenotypes. Weighted Gene Co-expression Network Analysis (WGCNA) revealed lncRNAs and mRNAs that were core and others associated with the PCOS phenotype. LIMITATIONS, REASONS FOR CAUTION: It remains unclear whether these differential transcripts contribute directly to follicular development or the pathogenesis of PCOS, or are merely biomarkers. WIDER IMPLICATIONS OF THE FINDINGS: It will be important in the future for investigators to ascertain the biologic mechanisms underlying the development of both normal and PCOS follicles. STUDY FUNDING/COMPETING INTEREST(S): This work was supported by the National Natural Science Foundation of China (No. 81671423, No. 81402130 and No. 81501247), the Fok Ying Tung Education Foundation (No. 151039), and Distinguished Talent Program of Shengjing Hospital (No. ME76). No competing interests declared.

Exosomal lncRNA and mRNA profiles in polycystic ovary syndrome: bioinformatic analysis reveals disease-related networks

Profiles for Long Non-Coding RNAs in Ovarian Granulosa Cells from Women with PCOS with or Without Hyperandrogenism.

160.Ovarian Leukocytes and Cytokines in Polycystic Ovary Syndrome

Ovarian Leukocyte Distribution and Cytokine/chemokine Mrna Expression in Follicular Fluid Cells in Women with Polycystic Ovary Syndrome.

Analysis of Long Non-Coding RNA Expression Profiles Using RNA Sequencing in Ovarian Endometriosis.

Analysis of LncRNA-mRNA Co-Expression Profiles in Patients With Polycystic Ovary Syndrome: A Pilot Study

Construction of a ceRNA network in polycystic ovary syndrome (PCOS) driven by exosomal lncRNA

Differential Expression Profile of Plasma Exosomal Micrornas in Women with Polycystic Ovary Syndrome

Long Non-Coding RNAs: Novel Players in the Pathogenesis of Polycystic Ovary Syndrome

High-Throughput Sequencing Profiles About lncRNAs and mRNAs of Ovarian Granulosa Cells in Polycystic Ovary Syndrome

Integrated Transcriptome Analysis of Lncrna, Mirna, and Mrna Reveals Key Regulatory Modules for Polycystic Ovary Syndrome

Non-coding RNAs in Polycystic Ovary Syndrome: a Systematic Review and Meta-Analysis.

Differential expression of long non-coding RNA Regulator of reprogramming and its molecular mechanisms in polycystic ovary syndrome

Expression profiles of mRNA and long noncoding RNA in the ovaries of letrozole-induced polycystic ovary syndrome rat model through deep sequencing

Characterization of long non-coding RNA and messenger RNA profiles in follicular fluid from mature and immature ovarian follicles of healthy women and women with polycystic ovary syndrome.

High throughput microRNAs sequencing profile of serum exosomes in women with and without polycystic ovarian syndrome

Identification of small extracellular vesicle-linked miRNA specifically derived from intrafollicular cells in women with polycystic ovary syndrome

Identification of CCR7 As a Potential Biomarker in Polycystic Ovary Syndrome Through Transcriptome Sequencing and Integrated Bioinformatics

Aberrant miRNA-mRNA regulatory network in polycystic ovary syndrome is associated with markers of insulin sensitivity and inflammation

Exploring lncRNA expression in follicular fluid exosomes of patients with obesity and polycystic ovary syndrome based on high-throughput sequencing technology

Proteomics and bioinformatics analysis of follicular fluid from patients with polycystic ovary syndrome